PALISADE BIO, INC. — Director's Dealing 2023

Jun 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2023-06-11

Reporting Person: Csimma Cristina (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-11	Restricted Stock Units	$	A	6980	Acquired		Common Stock (6980)	Direct
2023-06-11	Common Stock Options	$1.60	A	9580	Acquired	2033-06-11	Common Stock (9580)	Direct

Footnotes

F1: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant.

F2: The grants vest fully on the one (1) year anniversary of the grant date.

F3: Each restricted stock unit represents the right to receive one share of common stock.

F4: N/A

F5: Each option represents the right to purchase one share of common stock at the exercise price.